Core Viewpoint - The stock of Yaoshi Bang (09885) has risen nearly 6%, currently trading at HKD 9.74, following the announcement of its inclusion in the MSCI China Small Cap Index, effective after the market close on August 26 [1] Group 1: Company Performance - Yaoshi Bang expects a significant increase in profit, projecting at least RMB 70 million for the half-year ending June 30, 2025, which is more than three times the RMB 21.8 million profit for the half-year ending June 30, 2024 [1] - The company has reported strong growth in its self-owned brand business, with GMV reaching RMB 717 million from January to April 2025, representing a year-on-year increase of 108.1% [1] - The self-owned brand business GMV has shown exceptional growth, reaching RMB 560 million, with a year-on-year increase of 532.3% [1] Group 2: Market Position - Longcheng Securities highlights Yaoshi Bang as a leader in the digital ecosystem construction of the domestic off-hospital pharmaceutical industry, indicating robust growth in both platform and self-operated businesses [1] - The company is transitioning from a strategy focused on "scale expansion" to one aimed at "profit enhancement," reflecting a strategic upgrade in its business model [1]
药师帮涨近6% 公司获纳入MSCI全球小型股指数 自有品牌业务规模呈高增长态势